101 related articles for article (PubMed ID: 8934607)
1. Regulation and interactions of transforming growth factor-beta with cardiovascular cells: implications for development and disease.
Saltis J; Agrotis A; Bobik A
Clin Exp Pharmacol Physiol; 1996 Mar; 23(3):193-200. PubMed ID: 8934607
[TBL] [Abstract][Full Text] [Related]
2. Activation of a serine/threonine kinase signaling pathway by transforming growth factor type beta.
Atfi A; Lepage K; Allard P; Chapdelaine A; Chevalier S
Proc Natl Acad Sci U S A; 1995 Dec; 92(26):12110-4. PubMed ID: 8618854
[TBL] [Abstract][Full Text] [Related]
3. The rise and fall of ceramide and 1,2-diacylglycerol (DAG): modulation by transforming growth factor-beta 1 (TGF beta 1) and by epidermal growth factor (EGF).
Goldkorn T; Ding T
Adv Exp Med Biol; 1997; 400A():461-72. PubMed ID: 9547591
[TBL] [Abstract][Full Text] [Related]
4. An emerging complexity of receptors for transforming growth factor-beta.
Derynck R; Chen RH; Ebner R; Filvaroff EH; Lawler S
Princess Takamatsu Symp; 1994; 24():264-75. PubMed ID: 8983081
[TBL] [Abstract][Full Text] [Related]
5. Transforming growth factor-beta type-II receptor signalling: intrinsic/associated casein kinase activity, receptor interactions and functional effects of blocking antibodies.
Hall FL; Benya PD; Padilla SR; Carbonaro-Hall D; Williams R; Buckley S; Warburton D
Biochem J; 1996 May; 316 ( Pt 1)(Pt 1):303-10. PubMed ID: 8645222
[TBL] [Abstract][Full Text] [Related]
6. Transforming growth factor-β signalling: role and consequences of Smad linker region phosphorylation.
Kamato D; Burch ML; Piva TJ; Rezaei HB; Rostam MA; Xu S; Zheng W; Little PJ; Osman N
Cell Signal; 2013 Oct; 25(10):2017-24. PubMed ID: 23770288
[TBL] [Abstract][Full Text] [Related]
7. Lack of responsiveness to TGF-beta1 in a thyroid carcinoma cell line with functional type I and type II TGF-beta receptors and Smad proteins, suggests a novel mechanism for TGF-beta insensitivity in carcinoma cells.
Heldin NE; Bergström D; Hermansson A; Bergenstråhle A; Nakao A; Westermark B; ten Dijke P
Mol Cell Endocrinol; 1999 Jul; 153(1-2):79-90. PubMed ID: 10459856
[TBL] [Abstract][Full Text] [Related]
8. Loss of responsiveness to transforming growth factor beta induces malignant transformation of nontumorigenic rat prostate epithelial cells.
Tang B; de Castro K; Barnes HE; Parks WT; Stewart L; Böttinger EP; Danielpour D; Wakefield LM
Cancer Res; 1999 Oct; 59(19):4834-42. PubMed ID: 10519393
[TBL] [Abstract][Full Text] [Related]
9. Decreased type II/type I TGF-beta receptor ratio in cells derived from human atherosclerotic lesions. Conversion from an antiproliferative to profibrotic response to TGF-beta1.
McCaffrey TA; Consigli S; Du B; Falcone DJ; Sanborn TA; Spokojny AM; Bush HL
J Clin Invest; 1995 Dec; 96(6):2667-75. PubMed ID: 8675633
[TBL] [Abstract][Full Text] [Related]
10. Colon cancer cells that are not growth inhibited by TGF-beta lack functional type I and type II TGF-beta receptors.
MacKay SL; Yaswen LR; Tarnuzzer RW; Moldawer LL; Bland KI; Copeland EM; Schultz GS
Ann Surg; 1995 Jun; 221(6):767-76; discussion 776-7. PubMed ID: 7794080
[TBL] [Abstract][Full Text] [Related]
11. Evidence for control of nitric oxide synthesis by intracellular transforming growth factor-beta1 in tumor cells. Implications for tumor development.
Lagadec P; Raynal S; Lieubeau B; Onier N; Arnould L; Saint-Giorgio V; Lawrence DA; Jeannin JF
Am J Pathol; 1999 Jun; 154(6):1867-76. PubMed ID: 10362813
[TBL] [Abstract][Full Text] [Related]
12. TGF-beta receptors: structure and function.
Lin HY; Moustakas A
Cell Mol Biol (Noisy-le-grand); 1994 May; 40(3):337-49. PubMed ID: 7920178
[TBL] [Abstract][Full Text] [Related]
13. Genealogy, expression, and cellular function of transforming growth factor-beta.
Govinden R; Bhoola KD
Pharmacol Ther; 2003 May; 98(2):257-65. PubMed ID: 12725873
[TBL] [Abstract][Full Text] [Related]
14. Role of transforming growth factor (TGF)-beta Type I and TGF-beta type II receptors in the TGF-beta1-regulated gene expression in pituitary prolactin-secreting lactotropes.
Sarkar DK; Pastorcic M; De A; Engel M; Moses H; Ghasemzadeh MB
Endocrinology; 1998 Aug; 139(8):3620-8. PubMed ID: 9681516
[TBL] [Abstract][Full Text] [Related]
15. Expression of recombinant extracellular domain of the type II transforming growth factor-beta receptor: utilization in a modified enzyme-linked immunoabsorbent assay to screen TGF-beta agonists and antagonists.
Fahey MS; Dawbarn D; Allen SJ; Paterson IC; Prime SS
Anal Biochem; 2001 Mar; 290(2):272-6. PubMed ID: 11237329
[TBL] [Abstract][Full Text] [Related]
16. Expression of transforming growth factor (TGF)-beta1, TGF-beta2, and TGF-beta3 and of type I and II TGF-beta receptors during the development of the human fetal ovary.
Schilling B; Yeh J
Fertil Steril; 1999 Jul; 72(1):147-53. PubMed ID: 10428164
[TBL] [Abstract][Full Text] [Related]
17. Differential expression of transforming growth factor-beta receptors I and II and activation of Smad 3 in keloid fibroblasts.
Chin GS; Liu W; Peled Z; Lee TY; Steinbrech DS; Hsu M; Longaker MT
Plast Reconstr Surg; 2001 Aug; 108(2):423-9. PubMed ID: 11496185
[TBL] [Abstract][Full Text] [Related]
18. Human mast cell migration in response to members of the transforming growth factor-beta family.
Olsson N; Piek E; ten Dijke P; Nilsson G
J Leukoc Biol; 2000 Mar; 67(3):350-6. PubMed ID: 10733095
[TBL] [Abstract][Full Text] [Related]
19. Production and action of transforming growth factor-beta in human osteoblast cultures: dependence on cell differentiation and modulation by calcitriol.
Kassem M; Kveiborg M; Eriksen EF
Eur J Clin Invest; 2000 May; 30(5):429-37. PubMed ID: 10809903
[TBL] [Abstract][Full Text] [Related]
20. Ovarian transforming growth factor-beta (TGF-beta) receptors: in-vitro effects of follicle stimulating hormone, epidermal growth factor and TGF-beta on receptor expression in human preantral follicles.
Roy SK; Kole AR
Mol Hum Reprod; 1998 Mar; 4(3):207-14. PubMed ID: 9570266
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
